Moderate

Obesity hypoventilation syndrome (Pickwickian syndrome; OHS)

obesity-hypoventilation-syndrome · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Obesity (BMI >=30) with chronic daytime hypercapnia (awake PaCO2 >6.0 kPa / 45 mmHg) not explained by another cause, usually with coexisting obstructive sleep apnoea. Often presents late with hypercapnic respiratory failure or decompensated cor pulmonale. Positive airway pressure therapy and weight management are the mainstays.

Red flags

  • Acute decompensation with worsening hypercapnia / drowsiness / CO2 narcosis
  • Signs of right heart failure / cor pulmonale
  • Severe hypoxaemia
  • Secondary polycythaemia
  • Over-sedation or injudicious high-flow oxygen precipitating hypercapnia

Assessment

Differential diagnosis

  • Obstructive sleep apnoea without hypoventilation
  • COPD / overlap syndrome
  • Neuromuscular disease (e.g. motor neurone disease, myopathy)
  • Chest-wall disease (kyphoscoliosis)
  • Central hypoventilation
  • Hypothyroidism
  • Sedative/opioid-induced hypoventilation

Investigations

  • Arterial blood gas — daytime hypercapnia (PaCO2 >6.0 kPa / 45 mmHg) +/- hypoxaemia; compensated respiratory acidosis with raised bicarbonate
  • Serum bicarbonate as a screening clue (elevated HCO3- suggests chronic hypercapnia)
  • Sleep study / polysomnography (confirms coexisting OSA and nocturnal hypoventilation)
  • Spirometry (often restrictive from obesity; exclude obstruction/COPD)
  • TFTs to exclude hypothyroidism; FBC (secondary polycythaemia)
  • Echocardiography if pulmonary hypertension / cor pulmonale suspected
  • CXR

Management

  • Suspect OHS in an obese patient with daytime somnolence, morning headache, and unexplained raised bicarbonate or hypercapnia
  • Confirm daytime hypercapnia on ABG and exclude other causes
  • Acute hypercapnic respiratory failure: start non-invasive ventilation (bilevel/BiPAP) with controlled oxygen; avoid over-oxygenation worsening CO2 retention
  • Arrange sleep study to characterise OSA/hypoventilation and titrate therapy
  • Stable: CPAP if predominant severe OSA; bilevel NIV if persistent hypoventilation or CPAP-refractory hypercapnia
  • Weight loss programme - dietary, pharmacological, and consider bariatric surgery referral (definitive for many)
  • Avoid sedatives/opioids; treat comorbidities (heart failure, pulmonary hypertension, metabolic)
  • Long-term follow-up for adherence, repeat ABG, and cor pulmonale surveillance

Drugs & doses

No specific pharmacotherapy for the hypoventilation itself — positive airway pressure is the treatment
Controlled supplemental oxygen titrated to SpO2 ~88-92% (avoid worsening hypercapnia); oxygen alone does not treat hypoventilation
Diuretic e.g. furosemide for fluid overload / cor pulmonale [verify dose]
Treat associated conditions (antihypertensives, heart failure therapy) as indicated
AVOID benzodiazepines/opioids/other respiratory depressants
Consider weight-loss pharmacotherapy (e.g. GLP-1 agonist) as adjunct per local pathway [verify eligibility]

Disposition

Admit acute hypercapnic failure for NIV (HDU/respiratory). Refer to sleep/respiratory service for PAP titration and to weight-management/bariatric services. Long-term respiratory follow-up.

Complications & pitfalls

  • Acute-on-chronic hypercapnic respiratory failure
  • Pulmonary hypertension and cor pulmonale
  • Secondary polycythaemia and thromboembolism
  • Increased peri-operative and critical-illness risk
  • Higher mortality than eucapnic obese OSA if untreated

Exam pearls

  • An unexplained raised serum bicarbonate in an obese sleepy patient is a key clue to chronic hypercapnia - check an ABG (AASM/ATS OHS guidance).
  • Most OHS patients have coexisting OSA; CPAP suffices for many, but persistent hypoventilation needs bilevel NIV.
  • Give oxygen cautiously - uncontrolled oxygen can worsen hypercapnia; target SpO2 88-92%.
  • Weight loss (including bariatric surgery) is the only disease-modifying treatment; PAP controls but does not cure.
  • Avoid sedatives and opioids, which blunt respiratory drive.
  • OHS is frequently undiagnosed until an acute hypercapnic crisis - consider it in recurrent 'COPD' admissions in obese non-smokers.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.